Nyxoah Stock (NASDAQ:NYXH)
Previous Close
$3.26
52W Range
$2.76 - $8.64
50D Avg
$3.22
200D Avg
$4.80
Market Cap
$124.36M
Avg Vol (3M)
$49.33K
Beta
0.88
Div Yield
-
NYXH Company Profile
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.